| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-17 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
3e-16 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-14 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
6e-14 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
6e-14 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-14 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-12 |
| mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-12 |
| mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
7e-12 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-11 |